within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AB23_CipaglucosidaseAlfa;

model CipaglucosidaseAlfa
  extends Pharmacolibrary.Drugs.ATC.A.A16AB23;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A16AB23</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cipaglucosidase alfa is a recombinant human acid alpha-glucosidase (GAA) enzyme replacement therapy (ERT) indicated for the treatment of Pompe disease, a lysosomal storage disorder caused by GAA deficiency. It is currently approved for use in combination with miglustat.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for adults with late-onset Pompe disease based on typical dosing and available regulatory documents. No peer-reviewed publications or DOIs report pharmacokinetic parameters for cipaglucosidase alfa.</p><h4>References</h4><ol><li><p>Byrne, BJ, et al., &amp; Mozaffar, T (2024). Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). <i>Journal of neurology</i> 271(4) 1787–1801. DOI:<a href=&quot;https://doi.org/10.1007/s00415-023-12096-0&quot;>10.1007/s00415-023-12096-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38057636/&quot;>https://pubmed.ncbi.nlm.nih.gov/38057636</a></p></li><li><p>Byrne, BJ, et al., &amp; Mozaffar, T (2024). Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. <i>Frontiers in neurology</i> 15 1451512–None. DOI:<a href=&quot;https://doi.org/10.3389/fneur.2024.1451512&quot;>10.3389/fneur.2024.1451512</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39494167/&quot;>https://pubmed.ncbi.nlm.nih.gov/39494167</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end CipaglucosidaseAlfa;
